Anti-CD20 [B20]

CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.

Contributors

Institute
Netherlands Cancer Institute
Cat. #: 154781
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cell biology;Immunology
Application: ELISA ; FACS ; IP
Target: CD20
Reactivity: Human
Host: Mouse
Class: Monoclonal
Alternate name: B-lymphocyte antigen CD2
Product description: CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
Conjugation: Unconjugated
Isotype: IgG1
Molecular weight: 35 kDa
Immunogen: Daudi cells (Burkitt lymphoma)
Myeloma used: Sp2/0-Ag14
Target background: CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
Format: Liquid
Concentration: 0.9-1.1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Hooijberg et al. 1996. Hybridoma. 15(1):23-31. PMID: 9064283.

Related Tools for Antibodies

Cat. # Tool Name
151015 Anti-CyclinA [E70.1] Key Info View Tool
151019 Anti-Mos [S3.1] Key Info View Tool
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151037 Anti-Cdk1 [17 (A17)] Key Info View Tool
151039 Anti-Integrin aVb3 [23C6] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.